Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can computer exercises sharpen thinking in mental illness?

NCT ID NCT07506070

Symptom relief Sponsor: The Royal Ottawa Mental Health Centre Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a type of cognitive training called Action-Based Cognitive Remediation (ABCR) can improve thinking skills in people with various psychiatric conditions like depression, schizophrenia, anxiety, PTSD, and autism. Participants will complete computer exercises and group discussions over 8 weeks to practice real-life tasks. The goal is to see if this training helps with memory, attention, and daily functioning better than no treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Action-Based Cognitive Remediation (ABCR) therapy
What this could lead to
If it works, this could provide a practical, non-drug therapy to help people with psychiatric disorders think more clearly and function better in daily life.
What could go wrong
This is a small, early-stage study (160 participants) testing a behavioral intervention, so results may not apply broadly. The therapy requires significant time commitment and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 160 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

May 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants must have been given a diagnosis of a psychiatric disorder (such as mood anxiety, psychotic disorders, etc. * Participants must have reported subjective cognitive difficulties associated with their psychiatric disorder * Participants must be capable of providing informed consent * Participants must have the ability to speak and read in either English or French * Participants must have no changes to their medication intake (such as starting or stopping medication or changing doses) within the past month before providing consent for participation Exclusion Criteria: * Participants will be excluded if they are hospitalized at the time of recruitment * Participants will be excluded if they have a confirmed diagnosis of an intellectual disability

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Anxiety and mood disorders are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

anxiety disorder autism spectrum disorder Bipolar and Related Disorders bipolar disorder Cognition Disorders Cognitive Dysfunction combat disorder major depressive disorder mood disorder post-traumatic stress disorder psychiatric disorder psychotic disorder Schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Anxiety and mood disorders Autism spectrum disorder Bipolar and related disorders Depression - major depressive disorder Psychiatric disorders PTSD - post traumatic stress disorder Schizophrenia and other psychotic disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.